1-3 of 3
Susan E. Bell, DPhil
Close
Sort by
Journal Articles

Minimal Residual Disease (MRD) in Myeloma: Independent Outcome Prediction and Sequential Survival Benefits per Log Tumour Reduction

Andy C Rawstron, BSc, PhD, Walter Gregory, PhD, Ruth M de Tute, Faith E Davies, MD, Susan E Bell, DPhil, Mark T Drayson, MDPhD, Gordon Cook, MD, Graham H Jackson, MD, James A Child, Gareth J. Morgan, MD PhD, Roger G Owen
Journal: Blood
Blood (2014) 124 (21): 3416.
https://doi.org/10.1182/blood.V124.21.3416.3416
Published: 2014
Journal Articles

Deletion 13, Detected by Metaphase Analysis, Is Not a Significant Prognostic Indicator In Myeloma

Fiona M. Ross, DPhil, Laura Chiecchio, PhD, GianPaolo Dagrada, BSc, William J Tapper, PhD, Zoe J Konn, BSc, Kan Luk Cheung, BSc, Rebecca KM Protheroe, BSc, David M Stockley, BSc, Susan E Bell, DPhil, Walter M Gregory, PhD, Alexander J Szubert, MSc, Gordon Cook, MD, Roger G. Owen, MD, Mark T. Drayson, MD, Graham Jackson, DM, Faith Davies, MD, PhD, J. Anthony Child, MD, Gareth J Morgan, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 2980.
https://doi.org/10.1182/blood.V116.21.2980.2980
Published: 2010
Journal Articles

Follow up Analysis for MRC Myeloma VII Trial.

Gareth J. Morgan, PhD, Faith E. Davies, MD, Kim Hawkins, MSc, Susan E. Bell, DPhil, Julia M. Brown, MSc, Roger G. Owen, MD, Mark T. Drayson, PhD, Peter J. Selby, MD, Anthony J. Child, MD, for the Medical Research Council Adult Leukaemia Working Party
Journal: Blood
Blood (2004) 104 (11): 927.
https://doi.org/10.1182/blood.V104.11.927.927
Published: 2004